Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand
- PMID: 2683797
- PMCID: PMC1880104
Subcellular distribution of estrogen receptor and progesterone receptor with and without specific ligand
Abstract
The estrogen receptor (ER) and progesterone receptor (PR) content of cultured human breast carcinoma cells (MCF-7) was determined by biochemical assay, immunoblot analysis, and immunohistochemical assay under varying conditions of hormonal stimulation. The ER and PR content in cytosolic and nuclear extracts varied with steroid treatment. However, both the amount and distribution of each receptor in these extracts was virtually the same when determined by steroid binding and immunoblot analyses. Two immunocytochemical parameters (staining intensity and proportion of cells stained) correlated with the quantitative analyses of ER and PR, but not with the subcellular distribution. When MCF-7 cells were grown for 4 days in charcoal-stripped serum without phenol red, 93% of total ER was found in the cytosol (10 mM KCl), whereas short-term treatment with 5 nM estradiol resulted in the appearance of 82% of total ER in the nuclear extract (400 mM KCl). With either cell treatment only nuclear staining for ER was observed. Progesterone receptor was virtually undetectable in the same cells by any method. After 4 days of treatment by 5 nM estradiol, PR was strongly induced (50-fold) in MCF-7 cells as determined by all three methods. As observed for ER, 95% of total induced PR was found in the cytosol in the absence of a progestin. Short-term treatment with 5 nM ORG 2058, a synthetic progestin, resulted in the appearance of 42% of total PR in the nuclear extract. However, only strong nuclear staining for PR was observed in either the presence or absence of a progestin. These findings are consistent with the current view of ER and PR as nuclear receptors present in at least two forms. One of these, the unoccupied form of the receptor, is easily removed from the nucleus by hypotonic buffers during the cell homogenization process and appears in the cytosolic extract. The other form of the receptor, the steroid-occupied form, is more tightly bound to nuclear components and is removed from nuclei only under more vigorous extraction conditions.
Similar articles
-
Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies.Cancer Res. 1988 Nov 15;48(22):6462-74. Cancer Res. 1988. PMID: 3180062
-
Quantitative immunological detection of estrogen receptors in nuclear pellets from human breast cancer biopsies.Cancer Res. 1986 Aug;46(8 Suppl):4251s-4255s. Cancer Res. 1986. PMID: 3015386
-
Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas.Cancer Res. 1989 Jul 15;49(14):4011-4. Cancer Res. 1989. PMID: 2736540
-
Structure and dynamics of the estrogen receptor.J Steroid Biochem. 1986 Jan;24(1):1-7. doi: 10.1016/0022-4731(86)90024-5. J Steroid Biochem. 1986. PMID: 3517497 Review.
-
The predictive value of steroid hormone receptor analysis in breast, endometrial and ovarian cancer.Med Oncol Tumor Pharmacother. 1986;3(3-4):197-210. doi: 10.1007/BF02934996. Med Oncol Tumor Pharmacother. 1986. PMID: 3543533 Review.
Cited by
-
A novel cell lysis approach reveals that caspase-2 rapidly translocates from the nucleus to the cytoplasm in response to apoptotic stimuli.PLoS One. 2013 Apr 15;8(4):e61085. doi: 10.1371/journal.pone.0061085. Print 2013. PLoS One. 2013. PMID: 23596516 Free PMC article.
-
Multidimensional proteomics for cell biology.Nat Rev Mol Cell Biol. 2015 May;16(5):269-80. doi: 10.1038/nrm3970. Epub 2015 Apr 10. Nat Rev Mol Cell Biol. 2015. PMID: 25857810 Review.
-
Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications.Cells. 2020 Dec 9;9(12):2644. doi: 10.3390/cells9122644. Cells. 2020. PMID: 33316954 Free PMC article. Review.
-
Use of four biomarkers to evaluate the risk of breast cancer subtypes in the women's contraceptive and reproductive experiences study.Cancer Res. 2010 Jan 15;70(2):575-87. doi: 10.1158/0008-5472.CAN-09-3460. Epub 2010 Jan 12. Cancer Res. 2010. PMID: 20068186 Free PMC article.
-
Demonstration of estrogen receptors and of estrogen responsiveness in the HKT-1097 cell line derived from diethylstilbestrol-induced kidney tumors.In Vitro Cell Dev Biol Anim. 2000 Nov-Dec;36(10):640-9. doi: 10.1290/1071-2690(2000)036<0640:doerao>2.0.co;2. In Vitro Cell Dev Biol Anim. 2000. PMID: 11229596
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials